HEART Stock Overview
Designs and develops an artificial heart. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Scandinavian Real Heart AB (Publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 18.30 |
52 Week High | SEK 97.80 |
52 Week Low | SEK 14.85 |
Beta | 0.10 |
11 Month Change | -6.63% |
3 Month Change | -17.94% |
1 Year Change | -61.06% |
33 Year Change | -95.74% |
5 Year Change | -98.39% |
Change since IPO | -95.43% |
Recent News & Updates
Recent updates
Shareholder Returns
HEART | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -3.7% | -4.1% | -2.1% |
1Y | -61.1% | -9.7% | 10.8% |
Return vs Industry: HEART underperformed the Swedish Medical Equipment industry which returned -4.1% over the past year.
Return vs Market: HEART underperformed the Swedish Market which returned 12.5% over the past year.
Price Volatility
HEART volatility | |
---|---|
HEART Average Weekly Movement | 8.7% |
Medical Equipment Industry Average Movement | 7.5% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.2% |
10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: HEART's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: HEART's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 15 | Ina Perkins | realheart.se |
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, pulsating left ventricle assist; PulsePump, pulsating flow for heart and lung machines; and Sternal Prosthesis, to fix the sternum after open-chest surgery.
Scandinavian Real Heart AB (Publ) Fundamentals Summary
HEART fundamental statistics | |
---|---|
Market cap | SEK 3.78b |
Earnings (TTM) | -SEK 76.92m |
Revenue (TTM) | SEK 20.79k |
Over9,999x
P/S Ratio-49.2x
P/E RatioIs HEART overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEART income statement (TTM) | |
---|---|
Revenue | SEK 20.79k |
Cost of Revenue | -SEK 13.64m |
Gross Profit | SEK 13.66m |
Other Expenses | SEK 90.58m |
Earnings | -SEK 76.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.37 |
Gross Margin | 65,718.68% |
Net Profit Margin | -370,025.47% |
Debt/Equity Ratio | 8.8% |
How did HEART perform over the long term?
See historical performance and comparison